Acute pelvic pain in women: rule out pregnancy, look for pelvic inflammatory disease
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
First tests (suspected pelvic inflammatory disease)
Laboratory tests
- hCG (immediate urine test or serum β-hCG)
- Positive hCG: see the page "Bleeding or pelvic pain in early pregnancy" (ectopic pregnancy).
- HIV serology
- Syphilis serology
- FBCif neededTo judge severity: a raised CRP supports the diagnosis but is not specific, and CRP as well as leucocytes are often normal in mild or moderate forms [2]; normal values do not exclude upper genital tract infection. The CNGOF and SPILF advise FBC and CRP for any suspected upper genital tract infection (grade C): leucocytosis and raised CRP suggest a complicated form or another diagnosis, such as appendicitis [3].
- CRPif neededTo judge severity: a raised CRP supports the diagnosis but is not specific, and CRP as well as leucocytes are often normal in mild or moderate forms [2]; normal values do not exclude upper genital tract infection. The CNGOF and SPILF advise FBC and CRP for any suspected upper genital tract infection (grade C): leucocytosis and raised CRP suggest a complicated form or another diagnosis, such as appendicitis [3].
Speculum sample (endocervix; vaginal failing that)
- Endocervical sample: direct examination, culture (including gonococcus) with susceptibility testing
- Chlamydia trachomatis and Neisseria gonorrhoeae NAAT (PCR) (endocervix)
- Mycoplasma genitalium NAAT (PCR) (multiplex Chlamydia, gonococcus and M. genitalium, in place of the previous one)if neededRecommended for any suspected upper genital tract infection [2,4]. The NABM reimburses multiplex PCR only in case of observed acute cervicitis (or urethritis, or an infected partner) [5]: without cervicitis, write NR (not reimbursable).
- Hepatitis B serology (HBsAg, anti-HBs, anti-HBc), if status unknownif neededConfirmed or suspected STI, vaccination status unknown: screening for other STIs, including hepatitis B (see the page "Sexually transmitted infections").
Urine tests
- Urine dipstick (if urinary signs, to rule out urinary infection)if needednon-French guidelineDysuria or frequency: urinary tract infection is part of the differential diagnosis in the UK and the Netherlands [6,7]. Australia does urine tests for any recent pelvic pain in a woman of childbearing potential [8], and an American Family Physician review proposes considering it [9]. The French recommendation asks to look for urinary signs on history, without providing for a urine test [3].
Do not order
- Chlamydia serology when a direct sample is possible: it is useful only in upper genital tract infection when no sample is possible [10] (the NABM reimburses it for suspected upper tract infection, lymphogranuloma venereum, hypofertility and reactive arthritis) [5]. For the CNGOF and SPILF, it has no value either for diagnosing acute upper genital tract infection or for monitoring [3].
Follow-up after pelvic inflammatory disease
3 to 6 months after treatment
- Chlamydia trachomatis and Neisseria gonorrhoeae NAAT (PCR) on a vaginal sample, self-sampling possible (upper genital tract infection associated with an STI)
- Earlier follow-up only if symptoms persist, if adherence was poor or if a partner was not treated.
Do not order
- Routine bacteriological check after an upper genital tract infection not related to an STI: no basis according to the CNGOF and SPILF [3].
Sources (11)
- Development of an algorithm to identify pelvic inflammatory diseases using regional electronic hospital records: first step to assess the burden of Chlamydia trachomatis infections. BMJ Open 2026;16:e111779.
- Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29(2):108-14.
- Collège national des gynécologues et obstétriciens français (CNGOF), Société de pathologie infectieuse de langue française (SPILF). Les infections génitales hautes : mise à jour des recommandations pour la pratique clinique (texte court). Gynecol Obstet Fertil Senol. 2019;47(5):398-403. Version anglaise : Brun JL, Castan B, de Barbeyrac B, et al. Pelvic inflammatory diseases: updated French guidelines. J Gynecol Obstet Hum Reprod. 2020;49(5):101714.
- Haute Autorité de santé, Conseil national du sida et des hépatites virales, ANRS-MIE. Traitement curatif des personnes infectées par Mycoplasma genitalium. Recommandation de bonne pratique, avril 2025.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 5202 (prélèvement génital féminin), 5301 et 5304 (amplification génique Chlamydia, gonocoque, Mycoplasma genitalium), 1307 (sérologie Chlamydia).
- Ross J, Cole M, Evans C, Lyons D, Dean G, Cousins D. United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease (2019 Interim Update). British Association for Sexual Health and HIV.
- Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG). Richtlijn Pelvic Inflammatory Disease, modules « Microbiologisch onderzoek » et « Klinische criteria », publiée le 16 avril 2020.
- ASHM. Australian STI Management Guidelines for Use in Primary Care : Pelvic Inflammatory Diseases (PID), consulté le 30 octobre 2026.
- Frasca DJ, Jarrio CE, Perdue J. Evaluation of Acute Pelvic Pain in Women. Am Fam Physician. 2023;108(2):175-180.
- Haute Autorité de santé, Conseil national du sida et des hépatites virales, ANRS-MIE. Traitement curatif des personnes infectées par Chlamydia trachomatis. Recommandation de bonne pratique, avril 2025.
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187 (partie « Pelvic Inflammatory Disease »).